Unique ID issued by UMIN | UMIN000031920 |
---|---|
Receipt number | R000035761 |
Scientific Title | Evaluation of changes in intestinal flora in healthy person with half-elemental diet (900 kcal / day) |
Date of disclosure of the study information | 2018/03/31 |
Last modified on | 2019/01/18 14:39:57 |
Evaluation of changes in intestinal flora in healthy person with half-elemental diet (900 kcal / day)
Evaluation of half-ED
Evaluation of changes in intestinal flora in healthy person with half-elemental diet (900 kcal / day)
Evaluation of half-ED
Japan |
Healthy person
Gastroenterology |
Others
NO
We evaluate the change of intestinal flora by healthy persons with Half-ED (900 kcal / day) for 2 weeks, and aim to acquire basic data for elucidating the mechanism of action of nutritional therapy and develop it into the next research.
Efficacy
Evaluation of intestinal flora change by combining analysis results below.
1) fecal analysis (collected at 2, 4, 6 week)
16S metagenomic analysis, metabolome analysis
2) Blood biochemistry (collected at 2, 4, 6 weeks)
nutritional indicators (ALB, TP, TC), amino acids, fatty acids
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
1) Dietary guidance period (2 weeks)
Provide meal guidance by meal instruction instructor.
2) Half-ED period (2 weeks)
Reduce normal meal volume to about half and administer ED 900 kcal/day.
3) Normal diet period (2 weeks)
Return to normal meal intake.
20 | years-old | <= |
65 | years-old | >= |
Male and Female
Healthy person
Exclusion criteria are shown below.
1) Person with history of IBD
2) Person who underwent laparotomy surgery within half a year from the start of the study
3) Person with taking antibiotics within half a year of start the study
4) Major drinkers
5) Person with regularly taking medications
6) Person who can not refrain from intake of foods, supplements, medicines that affect the intestinal environment during the test period
7) Person with metabolism abnormality such as diabetes
8) Person with amino acid metabolic abnormality
9) Person with history of hypersensitivity to the study drug
10) Person with pregnancy / breast-feeding
11) Person who plans to change life style significantly during the examination period
12) Person who has chronic diarrhea easily
13) Person who participated in other clinical trials within the past 3 months
14) Person who can not obtain consent of participation in this clinical study
15) Person who is judged by study responsible doctor as inappropriate as subject
4
1st name | |
Middle name | |
Last name | Tadakazu Hisamatsu |
Kyorin University School of Medicine
The Third Department of Internal Medicine
6-20-2 Shinkawa, Mitaka-shi, Tokyo 181-8611, Japan
+81-422-47-5511
thisamatsu@ks.kyorin-u.ac.jp
1st name | |
Middle name | |
Last name | Daisuke Saito |
Kyorin University School of Medicine
The Third Department of Internal Medicine
6-20-2 Shinkawa, Mitaka-shi, Tokyo 181-8611, Japan
+81-422-47-5511
straw@zb3.so-net.ne.jp
Kyorin University School of Medicine
EA Pharma Co.,Ltd.
Profit organization
NO
2018 | Year | 03 | Month | 31 | Day |
Unpublished
Completed
2018 | Year | 01 | Month | 26 | Day |
2018 | Year | 03 | Month | 31 | Day |
2019 | Year | 01 | Month | 18 | Day |
2019 | Year | 01 | Month | 18 | Day |
2019 | Year | 01 | Month | 18 | Day |
2019 | Year | 01 | Month | 18 | Day |
2018 | Year | 03 | Month | 27 | Day |
2019 | Year | 01 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035761